Tenax Therapeutics, Inc.
TENX
$14.28
$0.443.18%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -198.82% | -197.55% | -150.42% | -139.64% | -128.27% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,569.25% | 6,908.68% | 3,905.35% | 1,824.34% | 431.24% |
| Change in Net Operating Assets | -243.88% | 10.34% | 118.29% | 404.56% | 3.79% |
| Cash from Operations | -141.71% | -107.98% | -73.26% | -77.76% | -150.86% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | 50.84% | 31.36% | 19.72% |
| Issuance of Common Stock | 736.87% | 101.70% | 245,100.00% | 3,037.09% | -87.37% |
| Repurchase of Common Stock | -- | 87.61% | 87.85% | 87.84% | 87.84% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -76.85% | -77.77% | 413.70% | 413.72% | 606.76% |
| Cash from Financing | -61.44% | -72.93% | 1,457.44% | 1,444.83% | 636.02% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -96.81% | -98.79% | 2,496.02% | 5,399.43% | 1,009.27% |